Germline testing for melanoma-associated cancer predisposition genes (Invitae Melanoma Panel) was negative for mutations in BAP1, BRCA1/2, CDK4, CDKN2A, MC1R, MITF, POT1, PTEN, RB1, TERT, and TP53. This evidence concerns the gene TERT and melanoma.